Risk factors of metabolic dysfunction-associated fatty liver disease in people with HIV receiving antiretroviral therapy
The prevalence of MAFLD as assessed by the HSI and ZJU indices increases steadily with ART and is strongly related to weight gains. These findings validate the effectiveness of these noninvasive tools for identifying key risk factors and underscore the necessity of continuous weight monitoring in contemporary ART-treated patients.
Authors
- Xien Gui (ORCID: https://orcid.org/0000-0002-3229-8628)
- Liping Deng (ORCID: https://orcid.org/0000-0002-7651-0096)
- Yajun Yan (ORCID: https://orcid.org/0000-0002-9993-3016)
- Yong Xiong (ORCID: https://orcid.org/0000-0003-0678-4064)
- Rongrong Yang (ORCID: https://orcid.org/0009-0008-6125-1491)
- Qianhui Chen (ORCID: https://orcid.org/0009-0002-6651-9684)
- Fei Ran Li (ORCID: https://orcid.org/0000-0002-2455-4986)
- Rui Yuan
Institutions
- Sichuan University (CN)
- AIDS United (US)
- Wuhan University (CN)
- West China Hospital of Sichuan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
Publication Details
- Journal
- AIDS
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1097/qad.0000000000004419
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00